Verminderte Knochendichte und Veränderungen im ...

Literaturverzeichnis
79. Hermus AR, Smals AG, Swinkels LM, et al. Bone mineral density and bone
turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab.
1995;80:2859-65.
80. Herold G. Osteoporose. In Herold et al., Innere Medizin. 2005; 655-658, Köln,
2005.
81. Herran A, Amado JA, Garcia-Unzueta MT, Vazquez-Barquero JL, Perera L,
Gonzalez-Macias J. Increased bone remodeling in first-episode major depressive
disorder. Psychosom Med. 2000;62:779-82.
82. Hestad KA, Tonseth S, Stoen CD, Ueland T, Aukrust P. Raised plasma levels of
tumor necrosis factor alpha in patients with depression: normalization during
electroconvulsive therapy. J Ect. 2003;19:183-8.
83. Heuser I. Anna-Monika-Prize paper. The hypothalamic-pituitary-adrenal system in
depression. Pharmacopsychiatry. 1998;31:10-3.
84. Hofbauer LC, A.E. Heufelder. Osteoprotegerin-Ligand und Osteoprotegerin.
Dtsch. Med. Wschr. 2001;126:145-150.
85. Hofbauer LC, Gori F, Riggs BL, et al. Stimulation of osteoprotegerin ligand and
inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage
cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis.
Endocrinology. 1999;140:4382-9.
86. Holick MF, Krane MS. Endokrinologie und Stoffwechsel, Abschnitt 2:
Erkrankungen des Knochen- und Mineralstoffwechsels. In:Dietel M, Duddenhausen J,
Suttorp N (Hrsg.): Harrisons Innere Medizin. 2002;15.Auflage(2394-2439): AWB
Wissenschaftsverlag Berlin.
87. Holsboer F. The Corticosteroid Receptor Hypothesis of Depression.
Neuropsychopharmacology. 2000;23:477-501.
88. Holsboer F, Von Bardeleben U, Gerken A, Stalla GK, Muller OA. Blunted
corticotropin and normal cortisol response to human corticotropin-releasing factor in
depression. N Engl J Med. 1984;311:1127.
89. Hopper J. The Bone Density of Female Twins Discordant for Tobacco Use. N Engl
J Med. 1994;330:387-392.
67